Detalhe da pesquisa
1.
Immunogenicity, safety, and tolerability of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in recipients of allogeneic hematopoietic stem cell transplant aged ≥2 years: an open-label study.
Clin Infect Dis
; 61(3): 313-23, 2015 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25870329
2.
Phase 3 Safety and Immunogenicity Study of a Three-dose Series of Twenty-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers.
Pediatr Infect Dis J
; 43(6): 587-595, 2024 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38456705
3.
A phase 3 randomized study to evaluate safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in healthy Japanese infants.
Int J Infect Dis
; 141: 106942, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38242195
4.
Development and validation of a 6-plex Luminex-based assay for measuring human serum antibodies to group B streptococcus capsular polysaccharides.
Hum Vaccin Immunother
; 20(1): 2311480, 2024 Dec 31.
Artigo
Inglês
| MEDLINE | ID: mdl-38608171
5.
Interlaboratory comparison of a multiplex immunoassay that measures human serum IgG antibodies against six-group B streptococcus polysaccharides.
Hum Vaccin Immunother
; 20(1): 2330138, 2024 Dec 31.
Artigo
Inglês
| MEDLINE | ID: mdl-38608170
6.
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in Mexico.
Rev Panam Salud Publica
; 33(6): 414-21, 2013 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-23939366
7.
A randomized, open-label, phase 3 study evaluating safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in Chinese infants and children under 6 years of age.
Hum Vaccin Immunother
; 19(2): 2235926, 2023 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37549923
8.
Safety and immunogenicity of a multivalent pneumococcal conjugate vaccine given with 13-valent pneumococcal conjugate vaccine in healthy infants: A phase 2 randomized trial.
Hum Vaccin Immunother
; 19(2): 2245727, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37927075
9.
Advances towards licensure of a maternal vaccine for the prevention of invasive group B streptococcus disease in infants: a discussion of different approaches.
Hum Vaccin Immunother
; 18(1): 2037350, 2022 12 31.
Artigo
Inglês
| MEDLINE | ID: mdl-35240933
10.
Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants in the United States.
Pediatr Infect Dis J
; 40(10): 944-951, 2021 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34525007
11.
A phase 3, multicenter, single-arm, open-label study to assess the safety, tolerability, and immunogenicity of a single dose of 13-valent pneumococcal conjugate vaccine in Japanese participants aged 6-64 years who are considered to be at increased risk of pneumococcal disease and who are naive to pneumococcal vaccines.
Vaccine
; 39(43): 6414-6421, 2021 10 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34563397
12.
Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial.
Lancet Infect Dis
; 21(2): 263-274, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32891191
13.
Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine Administered in a 3 + 1 versus 2 + 1 Dose Schedule Among Infants in China.
Pediatr Infect Dis J
; 38(11): 1150-1158, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31626050
14.
Evaluation of a Validated Luminex-Based Multiplex Immunoassay for Measuring Immunoglobulin G Antibodies in Serum to Pneumococcal Capsular Polysaccharides.
mSphere
; 3(4)2018 08 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30089644
15.
Development and Validation of 13-plex Luminex-Based Assay for Measuring Human Serum Antibodies to Streptococcus pneumoniae Capsular Polysaccharides.
mSphere
; 3(4)2018 08 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30089645
16.
A randomized study of fever prophylaxis and the immunogenicity of routine pediatric vaccinations.
Vaccine
; 35(15): 1926-1935, 2017 04 04.
Artigo
Inglês
| MEDLINE | ID: mdl-28262330
17.
Circulating Antibody 1 and 2 Years After Vaccination With the 13-Valent Pneumococcal Conjugate Vaccine in Preterm Compared With Term Infants.
Pediatr Infect Dis J
; 36(3): 326-332, 2017 03.
Artigo
Inglês
| MEDLINE | ID: mdl-27902652
18.
Long-term antibody persistence study (3 years after last dose) of the 7-valent pneumococcal conjugate vaccine in young children in China.
Vaccine
; 34(44): 5359-5365, 2016 10 17.
Artigo
Inglês
| MEDLINE | ID: mdl-27616471
19.
Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine Compared With 7-valent Pneumococcal Conjugate Vaccine Among Healthy Infants in China.
Pediatr Infect Dis J
; 35(9): 999-1010, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27254028
20.
Safety, tolerability, and immunogenicity of 7-valent pneumococcal conjugate vaccine in older infants and young children in China who are naive to pneumococcal vaccination: Results of a phase 4 open-label trial.
Vaccine
; 33(30): 3580-5, 2015 Jul 09.
Artigo
Inglês
| MEDLINE | ID: mdl-26044498